Option Care Health, Inc. (NASDAQ:OPCH) Position Boosted by Comerica Bank

Comerica Bank increased its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 13.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,357,628 shares of the company's stock after buying an additional 157,198 shares during the period. Comerica Bank owned about 0.80% of Option Care Health worth $31,497,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Barclays PLC increased its position in Option Care Health by 180.1% during the 3rd quarter. Barclays PLC now owns 310,194 shares of the company's stock worth $9,708,000 after purchasing an additional 199,454 shares in the last quarter. Central Pacific Bank Trust Division raised its position in shares of Option Care Health by 6.9% in the fourth quarter. Central Pacific Bank Trust Division now owns 10,079 shares of the company's stock valued at $234,000 after buying an additional 650 shares during the last quarter. Nordea Investment Management AB raised its position in shares of Option Care Health by 6.0% in the fourth quarter. Nordea Investment Management AB now owns 94,641 shares of the company's stock valued at $2,165,000 after buying an additional 5,365 shares during the last quarter. Harbor Capital Advisors Inc. lifted its stake in shares of Option Care Health by 2.7% during the fourth quarter. Harbor Capital Advisors Inc. now owns 213,155 shares of the company's stock valued at $4,945,000 after buying an additional 5,595 shares during the period. Finally, Graypoint LLC acquired a new stake in Option Care Health during the fourth quarter worth approximately $1,161,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and raised their price objective for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JPMorgan Chase & Co. boosted their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, Option Care Health currently has an average rating of "Moderate Buy" and a consensus price target of $35.50.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.64% of the stock is currently owned by company insiders.

Option Care Health Price Performance

Shares of Option Care Health stock traded up $0.12 during trading on Tuesday, hitting $32.93. The stock had a trading volume of 468,441 shares, compared to its average volume of 1,823,059. The business has a fifty day moving average of $33.34 and a two-hundred day moving average of $28.82. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The firm has a market cap of $5.39 billion, a P/E ratio of 27.59, a PEG ratio of 2.30 and a beta of 0.76. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. During the same quarter last year, the firm posted $0.26 EPS. The business's revenue for the quarter was up 16.3% on a year-over-year basis. On average, sell-side analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.